DGDamla Geçkalan

Damla Geçkalan

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Damla Geçkalan has a total of 320 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Combating Measles Transmission in the General Pediatrics Ward

    by Elif Kıymet, Yıldız Ekemen Keleş, Damla Geçkalan, Güneş Şenol, Yusuf Özdemir, Selen Gürsoy Turan, Özgür Olukman

  • Genel Pediyatri Servisinde Kızamık Bulaşı ile Mücadele

    by Elif Kıymet, Yıldız Ekemen Keleş, Damla Geçkalan, Güneş Şenol, Yusuf Özdemir, Selen Gürsoy Turan, Özgür Olukman

  • Clinical characteristics and predictors of severe pertussis in hospitalized children after the COVID-19 period in Türkiye: a multicenter study

    by Sevliya Ocal-Demir, Pınar Canizci Erdemli, Esra Cakmak Taskin, Ayşe Tekin Yilmaz, Semra Bayturan Şen, Deniz Ergün, Hincal Ozbakir, Berna Çetin Kahraman, Canan Özlü, Berker Okay, et al.

    Pertussis resurged globally, after the relaxation of COVID-19 measures, underscoring its continued relevance as a public health concern, yet data remain li


  • Open Access

    Symptoms and quality of life in long COVID-19: effects on children and parents

    by Yasin Yılmaz, Damla Geckalan, Veysel Nijat Baş

    The COVID-19 pandemic has negatively affected physical and mental well-being, reducing the quality of life of both pediatric patients and their families. Objective: To evaluate acute and post-infection COVID-19 symptoms in children and assess their impact on the quality of life of patients and their parents. Patients and Method: Cross-sectional study. 231 children aged 8–18 years diagnosed with long COVID-19 and their parents were included. Long COVID-19 was defined as the persistence of symptoms 3 months after the acute episode. A control group of 176 healthy children, matched for age and sex, and their parents, was also included. Demographic data and symptoms during infection and three months post-infection were recorded. Children completed the Pediatric Quality of Life Inventory (PedsQL™ 4.0, Turkish version), while parents completed the PedsQL™ Family Impact Module. Results: Fatigue (49.3%) was the most common symptom during the acute phase, followed by sore throat (39.8%), headache (39.3%), cough (27.7%), and joint pain (26.4%). 76.2% of children reported persistent symptoms, the most common being fatigue (15.9%), cough (15.3%), cognitive dysfunction (15.3%), headache (10.2%), and anosmia/ageusia (9%). According to the PedsQL™ questionnaires, children with COVID-19 and their parents showed significantly lower quality of life scores compared to controls (p < 0.001). Conclusion: COVID-19 infection negatively impacts the quality of life of both pediatric patients and their families, especially due to persistent symptoms such as attention deficit and poor academic performance. Comprehensive physical and psychological follow-up during and after the pandemic is recommended.

  • EEG and clinical findings in pediatric epilepsy and control groups using video‐based pattern stimulation

    by Hande Gazeteci Tekin, Fatma Kuşgöz, Damla Geçkalan

    Objective: This study aimed to compare EEG responses and clinical findings during video‐based pattern stimulation in pediatric epilepsy and control groups, and to evaluate differences according to epilepsy subgroups and seizure control status. Methods: A total of 438 children (190 with epilepsy, 248 controls) were included. All participants underwent a 100‐second video protocol consisting of 10 different patterns. Epileptiform activity during pattern stimulation and simultaneous clinical symptoms (nausea, dizziness, lightheadedness, etc.) were recorded. Responses to hyperventilation and photic stimulation were also assessed. The epilepsy group was analyzed according to seizure control (controlled/uncontrolled) and epilepsy syndromes (juvenile idiopathic generalized epilepsy, childhood absence epilepsy, self‐limited epilepsy with autonomic seizures (SeLEAS), self‐limited epilepsy with centrotemporal spikes (SeLECTS), and focal epilepsy). Statistical analyses were performed using chi‐square tests and multivariable logistic regression. Results: EEG pattern sensitivity was observed in 8.9% of the epilepsy group and 3.2% of controls ( p = .012). Clinical symptoms occurred in 11.5% of epilepsy patients and 15.7% of controls ( p = .265). Pattern sensitivity was significantly higher in uncontrolled epilepsy ( p = .009). Subgroup analysis revealed the most prominent difference in juvenile idiopathic generalized epilepsy. In multivariable analysis, hyperventilation ( p = .044) and photic response ( p = .042) were identified as independent predictors of pattern sensitivity. Significance: Pattern sensitivity is not exclusive to children with epilepsy and may also occur at a lower rate in healthy controls. Children with uncontrolled epilepsy and those with juvenile idiopathic generalized epilepsy (JIGE) are particularly at risk. EEG abnormalities during pattern stimulation provide a more reliable indicator than clinical symptoms. The video‐based protocol used in this study increases ecological validity by mimicking real‐life visual stimuli. Our findings support the need for international standardization of pattern stimulation, similar to hyperventilation and photic stimulation protocols.

  • Open Access

    Evaluation of cardiac repolarization inhomogeneity in children with type 1 diabetes mellitus

    by İlknur Elifoğlu, Rahmi Özdemir, Veysel Nijat Baş, Damla Geçkalan, Emine Değirmen Şişman

    Objective: Type 1 diabetes mellitus is the most common endocrine-metabolic disease in childhood, which progresses with insulin deficiency and can cause serious cardiovascular complications. Atrial and ventricular arrhythmias are important cardiovascular complications of diabetes. In this study, cardiac repolarization inhomogeneity in children with Type 1 diabetes mellitus was evaluated electrocardiographically. Method: Between February 2021 and April 2021, 48 patients with Type 1 diabetes mellitus and an equal number of healthy control groups were included in the study. Demographic characteristics of all cases were analyzed. P wave dispersion (PWd), QT interval (QT), QT dispersion (QTd), QTc interval (QTc), QTc dispersion (QTcd), Tpeak-Tend interval (Tp-e), Tp-e dispersion (Tp-ed) were evaluated with 12-lead electrocardiography, Tp-e/QT, Tp-Te/QTc ratios were calculated, and parameters were compared between both groups. Results: The mean age of the patient group was 11.44 ± 4 years, and the mean age of the control group was 9.97 ± 4.5 years. The study group consisted of 18 girls (37.5%) and 30 boys (62.5%). In the control group, there were 21 girls (43.7%) and 27 boys (56.3%). There was no significant difference between the patient and control groups in terms of age and gender. The disease duration of the cases was 35.10±30.7 months, and the HbA1c value was 8.4±1.75%. When heart rates, P wave duration, and PWd, QT, QTd, QTc, QTcd, Tp-e, Tp-ed values were compared between the patient and control groups, there was no statistically significant difference between the PWd, QT and QTc intervals, QTd, QTcd, Tp-e interval, Tp-e dispersion, Tp-e/QT, Tp-e/QTd measurements and ratios of the two groups (p>0.05). Conclusion: In our study, ventricular repolarization parameters of children with Type 1 diabetes and healthy children were found to be similar. Although we think the data we have obtained will contribute to the literature due to the limited number of studies on this subject in children, we believe that long-term and prospective studies involving more patients are needed.

  • Evaluation of autoimmune diseases in pediatric patients with type 1 diabetes mellitus

    by Onur Sivas, Damla Geçkalan, Veysel Nijat Baş

    Aim The incidence of other autoimmune diseases is higher in Type 1 Diabetes Mellitus (T1DM). Autoimmune thyroiditis and celiac disease often accompany T1DM. The aim of this study was to determine how frequently autoimmune thyroiditis and celiac disease occur at the time of diagnosis and during follow-up in T1DM pediatric patients. Methods Sixty pediatric patients were included in the study. As laboratory parameters, thyroid function tests (fT4, TSH), Anti-thyroid peroxidase antibody (a-TPO), serum thyroglobulin antibody (a-TG), tissue transglutaminase antibodies (TGA), islet cell antibody, anti insulin antibodies and HbA1c levels were evaluated. Results The average diabetes duration of the patients was 3.8 ± 3.2 years and the mean HbA1c value was 9.02% ± 2.18. In the T1DM cases, 36 of the 60 patients (60%) tested positive for any of the DM antibodies. TPO antibodies were found to be positive in 18 of the 60 patients (30%). Of these 18 patients, 15 were female (83.3%) and 3 were male (16.7%). TPO antibody positivity was statistically higher in females. All patients with positive TPO antibodies were diagnosed with autoimmune thyroiditis. TG antibodies were found to be positive in 9 of the 60 patients (15%), 8 of whom were female (88.8%) and 1 was male (11.2%). Tissue transglutaminase IgA antibodies were positive in 6 of the 60 patients (10%). Three of these patients (all of whom were female) were diagnosed with celiac disease. Conclusion Our study suggested that children diagnosed with type 1 diabetes should be followed up in terms of autoimmune thyroiditis and celiac disease.

  • Open Access

    Can hydroxychloroquine and azithromycin combination cause cardiac rhythm disturbances in children with COVID-19 pneumonia?

    by Damla Geçkalan, Rahmi Özdemir, Yasin Yılmaz, Cemile Hilal Çelik, Batuhan Berk Demir, Yeşim Tunç

    Aims: At the beginning of the COVID-19 pandemic; it has been shown that receiving hydroxychloroquine and azithromycin treatment decrease viral carriage of coronavirus in patients. In this study, we aimed to evaluate electrocardiography (ECG) abnormalities in pediatric patients with COVID-19 pneumonia receiving combined therapy with hydroxychloroquine and azithromycin. Methods: In this study; ECG and laboratory parameters of 24 children with COVID-19 pneumonia who were treated with hydroxychloroquine and azithromycin at Health Sciences University between June 2020 and November 2020 were analyzed retrospectively. P wave dispersion (PWd), QT interval (QT), QT dispersion (QTd), QTc interval (QTc), QTc dispersion (QTcd), Tpeak-Tend interval (Tp-e), Tp-e dispersion (Tp-ed), Tp-e/QT, Tp-Te/QTc ratios were evaluated with 12 lead ECG. ECG parameters and QTc interval were compared before and after (5 days) the treatment. Results: The mean age was 13±4.5 years and 62.5% were female. Median hospitalization length was 6 days. There was no statistically significant difference between the PWd, QT and QTc interval, QTd, QTcd, Tp-e interval, Tp-e dispersion, Tp-e/QT, Tp-e/QTd measurements and ratios of the before and after treatment. A significant difference was found for the decrease in hearth rate in regard to the measurement before and after the treatment. Conclusion: In our study, there were no rhythm problems which were observed on ECG in pediatric patients receiving hydroxychloroquine and azithromycin combination therapy for COVID-19 pneumonia. We also found that laboratory parameters were not specific for COVID-19 pneumonia in children.

  • Evaluation of Inflammatory, Cardiac and Hematological Parameters in Hospitalized Children with COVID-19

    by Damla Geçkalan, Rahmi Özdemir, Zülal Yılmaz, Onur Sivas, Yasin Yılmaz, Cemile Hilal Çelik

    Evaluation of Inflammatory, Cardiac and Hematological Parameters in Hospitalized Children with COVID-19 - Cam & Sakura Medical Journal

  • Evaluation of the Characteristics of Respiratory Viruses and Coinfections in Hospitalized Children during the COVID-19 Pandemic

    by Damla Geçkalan, Aynur Gülcan

    Objective Studies have shown that more than one viral agent is not uncommonly detected simultaneously in respiratory tract infections of children. The aim of this study was to analyze our single-center experience with the seasonal distribution, clinical and laboratory outcomes of respiratory viruses, and coinfections in hospitalized children during the coronavirus disease 2019 (COVID-19) pandemic. Methods During the pandemic period of June 1, 2021 to February 1, 2022, 156 pediatric patients hospitalized with non-COVID-19 respiratory tract infections were retrospectively analyzed. Among these children, 92 were found to be positive for respiratory pathogens. These children's ages, genders, polymerase chain reaction results, and blood parameters were analyzed. Results The median age of the patients was 8 months (10 days–17.1 years) and 63% were male. A total of 16.3% of the patients were neonates (0–28 days), 55.4% were infants (1–24 months), 16.3% were preschool (2–5 years), and 12% were school-aged (5–18 years); 73.9% of the patients were hospitalized in the pediatric ward, 16.3% in the neonatal intensive care unit, and 9.8% in the pediatric intensive care unit. In 76.5% of hospitalized patients, only one pathogen was identified. Respiratory syncytial virus was detected as a causative agent of either mono- or coinfections in 78.4% of all patients. There was no statistical difference between inflammatory parameters in the patients infected with single or multiple viral agents. Conclusion As a result of the precautions taken during the pandemic, we found that the viral distribution of respiratory tract infections changed. In addition, we believe that hematological parameters are not useful for distinguishing between mono- and coinfections.